Neonatology and Pediatric Intensive Care, Children's and Adolescents' Hospital, University Hospital of Cologne, Cologne, Germany.
Prenatal Medicine, Department of Obstetrics and Gynecology, University Hospital of Cologne, Cologne, Germany.
Pediatr Nephrol. 2018 Apr;33(4):651-659. doi: 10.1007/s00467-017-3812-3. Epub 2017 Oct 27.
Previous studies on renal oligohydramnios (ROH) report highly variable outcome and identify early onset of ROH and presence of extrarenal manifestations as predictors of adverse outcome in most cases. Data on termination of pregnancy (TOP) and associated parental decision-making processes are mostly missing, but context-sensitive for the interpretation of these findings. We provide here a comprehensive analysis on the diagnosis, prenatal decision-making and postnatal clinical course in all pregnancies with ROH at our medical centre over an 8-year period.
We report retrospective chart review data on 103 consecutive pregnancies from 2008 to 2015 with a median follow-up of 554 days.
After ROH diagnosis, 38 families opted for TOP. This decision was associated with onset of ROH (p < 0.001), underlying renal disease (p = 0.001) and presence of extrarenal manifestations (p = 0.02). Eight infants died in utero and 8 cases were lost to follow-up. Of the 49 liveborn children, 11 received palliative and 38 underwent active care. Overall survival of the latter group was 84.2% (n = 32) corresponding to 31% of all pregnancies (32 out of 103) analysed. One third of the surviving infants needed renal replacement therapy during the first 6 weeks of life.
Over one third of pregnancies with ROH were terminated and the parental decision was based on risk factors associated with adverse outcome. Neonatal death was rare in the actively treated infants and the overall outcome promising. Our study illustrates that only careful analysis of the whole process, from prenatal diagnosis via parental decision-making to postnatal outcome, allows sensible interpretation of outcome data.
先前关于肾脏羊水过少(ROH)的研究报告显示,其结局变化较大,且大多数情况下,ROH 的早期发病以及肾外表现的存在被认为是不良结局的预测因素。关于终止妊娠(TOP)和相关父母决策过程的数据大多缺失,但对于这些发现的解释具有上下文敏感性。在此,我们提供了在我们医疗中心的 8 年期间,对所有 ROH 妊娠的诊断、产前决策和产后临床过程的全面分析。
我们报告了 2008 年至 2015 年期间连续 103 例妊娠的回顾性图表数据,中位数随访时间为 554 天。
ROH 诊断后,38 个家庭选择 TOP。这一决策与 ROH 的发病(p<0.001)、潜在的肾脏疾病(p=0.001)和肾外表现的存在(p=0.02)相关。8 例胎儿在宫内死亡,8 例失访。在 49 例活产儿中,11 例接受姑息治疗,38 例接受积极治疗。后者的总生存率为 84.2%(n=32),相当于分析的所有妊娠(103 例中的 32 例)的 31%。三分之一存活的婴儿在生命的前 6 周需要肾脏替代治疗。
超过三分之一的 ROH 妊娠被终止,父母的决策是基于与不良结局相关的风险因素。积极治疗的婴儿中新生儿死亡罕见,整体预后良好。我们的研究表明,只有仔细分析从产前诊断到父母决策再到产后结局的整个过程,才能对结局数据进行合理的解释。